 
			| List | Section | Observation | 
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 09. ANTIPARKINSONISM MEDICINES | This medicine has the best evidence for effectiveness and safety. | 
| PAHO Strategic Fund Medicine List | 14. Antiparkinsonism medicines | Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. | 
| Peru | 09. Antiparkinsonians | No observations | 
| Ecuador | Essential Medicines List - Ecuador | No observations | 
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 26. Antiparkinsonianos | No observations | 
| Mexico. Cuadro Basico de Medicamentos - 2017 | 14. NEUROLOGIA | No observations | 
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | N. SISTEMA NERVOSO | No observations | 
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 04. ANTIPARKINSONIANOS | No observations | 
| El Salvador - 2019 | ANTIPARKINSONIANOS | No observations | 
| Suriname. NGK-C-011 | 09. Medications for Parkinson's Disease | No observations | 
| Belize. National Drug Formulary | 09. ANTIPARKINSONISM MEDICINES | No observations | 
| List | Section | Observation | 
|---|---|---|
| Haiti. National List of Essential Medicines | 09. Antiparkinsons | No observations | 
| List | Section | Observation | 
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC | Others observations: Chlorhidrato INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: FORMAS FARMACÉUTICAS QUE MODIFICAN LA LIBERACIÓN DEL PRINCIPIO ACTIVO | 
| List | Section | Observation | 
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 09. ANTIPARKINSONISM MEDICINES | This medicine has the best evidence for effectiveness and safety. | 
| PAHO Strategic Fund Medicine List | 14. Antiparkinsonism medicines | Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. | 
| Peru | 09. Antiparkinsonians | No observations | 
| Ecuador | Essential Medicines List - Ecuador | No observations | 
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 26. Antiparkinsonianos | No observations | 
| Mexico. Cuadro Basico de Medicamentos - 2017 | 14. NEUROLOGIA | No observations | 
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | N. SISTEMA NERVOSO | No observations | 
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 04. ANTIPARKINSONIANOS | No observations | 
| El Salvador - 2019 | ANTIPARKINSONIANOS | No observations | 
| Suriname. NGK-C-011 | 09. Medications for Parkinson's Disease | No observations | 
| Belize. National Drug Formulary | 09. ANTIPARKINSONISM MEDICINES | No observations | 
| List | Section | Observation | 
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | N. SISTEMA NERVOSO | No observations | 
| List | Section | Observation | 
|---|---|---|
| Belize. National Drug Formulary | 09. ANTIPARKINSONISM MEDICINES | No observations | 
| List | Section | Observation | 
|---|---|---|
| Haiti. National List of Essential Medicines | 09. Antiparkinsons | No observations |